External Validation of the GREAT Score in Turkish Patients with Graves' Hyperthyroidism Treated with the Titration Regimen Method of Antithyroid Drugs: A Multicenter Study

17Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

Recently, the Graves' Recurrent Events After Therapy score (GREAT) was proposed as a useful tool to predict relapse before starting antithyroid drugs (ATD) in patients with Graves' disease (GD). Therefore, we intended to assess the validity of the GREAT score in Turkish patients with GD, including patients who experienced a poorly controlled disease (multiple episodes of hyperthyroidism followed by euthyroidism or rarely hypothyroidism) during ATD dose titration. This is a retrospective multicenter study including 517 patients with the first episode of GD who were treated for at least 12 months. The patients were classified as relapse+poorly controlled disease (non-remission) and remission groups. During a median follow-up time of 35 months (12-144 months), 191 (37%) patients experienced a relapse, 136 (26.3%) a poorly controlled disease, and 190 (36.7%) remained in remission. Patients with non-remission disease tended to have significantly higher serum levels of TRAb, fT4, and fT3, and have larger goiter sizes on palpation at baseline, as compared with the remission group. Non-remission disease occurred in 12, 35, and, 53% of the patients falling into GREAT class I, II, and III, respectively (hazard ratio 2.56, 95% CI 2.02-3.51, p=0.012, and hazard ratio 3.54, 95% CI 2.12-5.91, p<0.001, for GREAT class II and III against class I, respectively). According to our study, the GREAT score is a useful tool to predict the risk of relapse as well as the occurrence of poorly controlled disease before starting treatment with ATDs.

References Powered by Scopus

2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis

1823Citations
N/AReaders
Get full text

Antithyroid drugs

978Citations
N/AReaders
Get full text

2018 European thyroid association guideline for the management of graves' hyperthyroidism

592Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Hyperthyroidism: aetiology, pathogenesis, diagnosis, management, complications, and prognosis

81Citations
N/AReaders
Get full text

Pathophysiology of thyroid-associated orbitopathy

27Citations
N/AReaders
Get full text

Appropriate duration of antithyroid drug treatment as a predictor for relapse of Graves’ disease: a systematic scoping review

14Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Zuhur, S. S., Elbuken, G., Yildiz, I., Kadioglu, P., Erol, S., Sahin, S., … Altuntas, Y. (2019). External Validation of the GREAT Score in Turkish Patients with Graves’ Hyperthyroidism Treated with the Titration Regimen Method of Antithyroid Drugs: A Multicenter Study. Hormone and Metabolic Research, 51(10), 627–633. https://doi.org/10.1055/a-0974-3991

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 3

60%

Researcher 2

40%

Readers' Discipline

Tooltip

Medicine and Dentistry 2

33%

Psychology 2

33%

Nursing and Health Professions 1

17%

Biochemistry, Genetics and Molecular Bi... 1

17%

Save time finding and organizing research with Mendeley

Sign up for free